ENTA
ENTA
NASDAQ · Biotechnology

Enanta Pharmaceuticals Inc

$11.00
+0.92 (+9.13%)
Next Earnings Report
Nov 16, 2026
After Market Close
5 days away
EPS Estimate $-0.80
Revenue Est $14.48M
Earnings Summary
Beats (Last 1) 0/1
Avg Surprise -28.8%
Latest EPS $-0.67
History 1 quarter
Earnings History
Date Quarter EPS Est EPS Actual Surprise Surprise % Result
Aug 10, 2026 Q3 FY2026 $-0.52 $-0.67 -$0.15 -28.8% Miss
May 11, 2026 Q2 FY2026 $-0.50 — — — —
Feb 9, 2026 Q1 FY2026 $-0.82 — — — —